The PNC Financial Services Group (NYSE:PNC – Get Free Report) had its price objective dropped by equities researchers at Truist Financial from $252.00 to $248.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “hold” rating on the financial services provider’s stock. Truist Financial’s price target would indicate […]

Exelon (NASDAQ:EXC – Free Report) had its target price lowered by Truist Financial from $48.00 to $46.00 in a report published on Friday,Benzinga reports. The firm currently has a hold rating on the stock. EXC has been the subject of a number of other research reports. Weiss Ratings restated a “buy (b-)” rating on shares […]

WEC Energy Group (NYSE:WEC – Free Report) had its price objective cut by Truist Financial from $114.00 to $113.00 in a report published on Friday morning,Benzinga reports. They currently have a hold rating on the utilities provider’s stock. Several other analysts have also recently issued reports on the company. LADENBURG THALM/SH SH cut WEC Energy […]

CNX Resources (NYSE:CNX – Free Report) had its target price trimmed by Truist Financial from $35.00 to $34.00 in a research note released on Friday morning, Marketbeat.com reports. The firm currently has a hold rating on the oil and gas producer’s stock. Other research analysts have also recently issued research reports about the stock. Mizuho […]

AMERISAFE (NASDAQ:AMSF – Free Report) had its target price lowered by Truist Financial from $32.00 to $27.00 in a research note released on Tuesday morning, Marketbeat reports. The brokerage currently has a hold rating on the insurance provider’s stock. Other research analysts have also issued reports about the company. Morgan Stanley set a $40.00 price […]

Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective dropped by analysts at Truist Financial from $34.00 to $33.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective indicates a potential upside of 48.92% from the stock’s current […]